发明授权
US08877736B2 Method for treating keloid by administering 3′sialyllactose or 6′sialyllactose as a pharmaceutical or cosmetic
有权
通过施用作为药物或化妆品的唾液乳糖或6唾液酸乳糖来治疗瘢痕疙瘩的方法
- 专利标题： Method for treating keloid by administering 3′sialyllactose or 6′sialyllactose as a pharmaceutical or cosmetic
- 专利标题（中）： 通过施用作为药物或化妆品的唾液乳糖或6唾液酸乳糖来治疗瘢痕疙瘩的方法
-
申请号： US13376463申请日： 2010-04-09
-
公开(公告)号： US08877736B2公开(公告)日： 2014-11-04
- 发明人: Seung Woo Kang
- 申请人： Seung Woo Kang
- 申请人地址： KR Seoul
- 专利权人： Benebiosis Co., Ltd.
- 当前专利权人： Benebiosis Co., Ltd.
- 当前专利权人地址： KR Seoul
- 代理机构： Clark & Elbing LLP
- 优先权： KR10-2009-0030995 20090409
- 国际申请： PCT/KR2010/002210 WO 20100409
- 国际公布： WO2010/117241 WO 20101014
- 主分类号： A61K31/702
- IPC分类号： A61K31/702 ; A61P17/02 ; C07D257/04 ; A61K31/7016 ; A61K8/60
摘要：
The present invention relates to a composition for preventing or treating hypertrophic scar or keloid, comprising as an active ingredient a compound represented by the following general formula I: S-(MS)p-(MS)q (I) wherein S represents sialic acid, and (MS)p and (MS)q independently represent a monosaccharide residue. The composition of the present invention inhibits proliferation of keloid fibroblasts and induces apoptosis of keloid fibroblasts, thereby effectively preventing or treating keloid. The active ingredient used in this invention is a natural compound or its derivative or isomer and therefore very safe to human.
公开/授权文献
信息查询
